Vanda Pharmaceuticals buy Truist Financial Co.
Start price
05.03.26
/
50%
€6.80
Target price
05.03.27
€15.49
Performance (%)
-10.29%
Price
02.04.26
€6.10
Summary
This prediction is currently active. The prediction for Vanda Pharmaceuticals disappoints with a performance of -10.29%. This prediction currently runs until 05.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vanda Pharmaceuticals | -1.613% | -1.613% |
| iShares Core DAX® | 2,49 % | |
| iShares Nasdaq 100 | 1,65 % | |
| iShares Nikkei 225® | 0,55 % | |
| iShares S&P 500 | 1,35 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda Pharmaceuticals (VNDA) is now covered by Truist Financial Corporation. They set a "buy" rating and a $18.00 price target on the stock.
Ratings data for VNDA provided by MarketBeat